- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01175577
Feeding the Rainbow to Investigate Endothelial Dysfunction (FRIED)
February 2, 2012 updated by: Ryan David Bradley, Bastyr University
Evaluating the Effects of Mixed-Carotenoids on Biomarkers of Endothelial Dysfunction
The primary purpose of this study is to compare the change in blood carotene concentration between a food-based versus nutritional supplement-based intervention.
This study will randomize up to 60 healthy volunteers to receive either carotenoid-enriched food; natural, mixed carotenoid supplementation; chlorophyll complex or placebo supplementation.
Blood carotene levels will be measured before and after 28 days of supplementation.
Preliminary data will also be collected on several biomarkers associated with vascular inflammation and endothelial dysfunction.
These biomarkers will be measured before and during a fast food control meal at the beginning and end of the intervention period.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Kenmore, Washington, United States, 98028
- Bastyr University Clinical Research Center
-
Seattle, Washington, United States, 98195
- University of Washington Clinical Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adults aged 18-65
- in good health by the absence of exclusion criteria on standardized medical history interview
- willingness to be randomized
- willingness to complete multiple blood draws following fast food consumption on two occasions over 28 days
Exclusion Criteria:
- children <18 years
- current use of carotenoid supplements (not including typical multivitamins containing beta-carotene)
- current use of polyphenol supplements including green tea, resveratrol, pine bark extract, cocoa, and/or grape skin extract
- current use of aspirin, statins or regular (>2 per week) use of NSAID medications
- current smoking or past smoking greater than 3 packs total or currently living with a smoker
- excessive alcohol intake (> 3 drinks per day) or history of alcoholism
- known exposure to asbestos
- autoimmune disease
- hemachromatosis
- history of gallbladder disease including gall stones or gall bladder removal
- pre-diabetes, metabolic syndrome or diabetes (1 or 2)
- established cardiovascular disease (arrhythmia, heart failure, hypertension treatment or untreated stage II hypertension (≥160/90; stage II technically diastolic ≥100mmHg, will maintain diastolic cutoff of 90mmHg), past MI or stroke)
- renal or liver disease (viral hepatitis, non-alcoholic steatohepatitis "fatty liver")
- acute infection except viral colds
- residual injury/pain/limitation from trauma
- chronic musculoskeletal disorders including osteoarthritis requiring pain medications
- psychiatric disorders that would impair completion of research tasks
- allergies to supplied foods
- anyone on a medically-prescribed diet
- >3.5 servings fruits/veggies per day
- inability to consume entire study Control meal w/in specified timeline (30 minutes)
- current pregnancy or breast feeding
- refusal to participate in blood draws following the control meal.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Safflower oil-filled capsules, one twice daily with meals
|
|
Active Comparator: Supplement 1
|
One capsule, twice daily with meals for 28 days
|
|
Active Comparator: Supplement 2
|
One capsule per day with meals for 28 days
|
|
Active Comparator: Food-based Intervention
|
Single carotenoid-enriched soup or salad serving eaten daily
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in serum carotenoid fraction concentrations between study arms
Time Frame: Following 28 day intervention
|
Following 28 day intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in oxidized LDL lipoproteins (oxLDL)
Time Frame: Following 28 day intervention
|
Following 28 day intervention
|
|
Change in serum gamma-glutamyl transferase (GGT)
Time Frame: Following 28 day intervention
|
Following 28 day intervention
|
|
Change in urinary isoprostanes
Time Frame: Following 28 day intervention
|
Following 28 day intervention
|
|
Change in serum antioxidant capacity (ORAC)
Time Frame: Following 28 day intervention
|
Following 28 day intervention
|
|
Change in lipid profile (LDL, HDL, triglycerides)
Time Frame: Following 28 day intervention
|
Following 28 day intervention
|
|
Change in C-reactive protein (CRP)
Time Frame: Following 28 day intervention
|
Following 28 day intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ryan D Bradley, ND, MPH, Bastyr University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2009
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
August 1, 2011
Study Registration Dates
First Submitted
August 3, 2010
First Submitted That Met QC Criteria
August 3, 2010
First Posted (Estimate)
August 5, 2010
Study Record Updates
Last Update Posted (Estimate)
February 3, 2012
Last Update Submitted That Met QC Criteria
February 2, 2012
Last Verified
February 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Disease
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingCardiovascular Disease (CVD) | Gender Incongruence | Cardiovascular (CV) Risk | Cardiovascular Health Status | Cardiovascular Disease Prevention | Cardiovascular Disease Acute | Cardiovascular Disease Risk FactorItaly
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular Disease | Inflammatory DiseaseUnited States
-
University College DublinBeacon Hospital, IrelandRecruitingCoronary Artery Disease (CAD) | Cardiovascular Diseases (CVD) | Cardiovascular Disease Prevention | Cardiovascular Disease Risk FactorIreland
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Istituti Clinici Scientifici Maugeri SpAA.R.C.A Associazioni Regionali Cardiologi AmbulatorialiRecruiting
-
AmgenRecruitingCardiovascular DiseaseItaly, Germany, United States, China, Japan, Spain, Denmark, Australia, France, Canada, Netherlands
-
University of ReadingBiotechnology and Biological Sciences Research Council; Royal Berkshire NHS...Not yet recruiting
-
Nanjing Medical UniversityRecruiting
-
Centre Hospitalier Universitaire de la RéunionRecruitingCardiovascular DiseaseFrance
Clinical Trials on Chlorophyll complex, Standard Process
-
Standard Process Inc.Completed
-
VA Office of Research and DevelopmentCompletedSurgery | Cholecystectomy, Laparoscopic | Arthroplasty, Replacement, Hip | Prostatectomy | Endarterectomy, CarotidUnited States
-
University of YalovaNot yet recruitingArtificial Intelligence | Nursing Education | Clinical Competence | Artificial Intelligence (AI) | Nursing Process | Nursing Process Competence | Artificial Intelligence Perception and AttitudeTurkey (Türkiye)
-
University of California, San DiegoCompleted
-
Logan College of ChiropracticUnknown
-
National Institute on Aging (NIA)Completed
-
South Tyneside and Sunderland NHS Foundation TrustNot yet recruitingBariatric Surgery Candidate | Informed Consent | Shared Decision Making
-
Dr. Boris ZevinCompletedCholecystectomy | Consent | LaparoscopicCanada
-
Poitiers University HospitalRecruitingDyspnea | Out-of-hospital SettingFrance
-
Standard Process Inc.Keiser University College of Chiropractic MedicineCompleted